Clinical Validation and Safety of the AC 12L ECG System Against a Standard of Care 12-Lead ECG (AC 12L ECG)

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT05617001

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05617001
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05617001. Allocation not applicable; no masking; primary purpose diagnostic. Start 2022-10-04 (actual); primary completion 2024-08 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Validation and Safety of the AC 12L ECG System Against a Standard of Care 12-Lead ECG (AC 12L ECG)
Condition
Arrhythmia
Intervention (Device)
Kardia 12L
Lead sponsor
University of Oklahoma (class: other)

Record details

Record id
cardio:ct-nct05617001
Content hash
3e1710dadf3aa4d1b2eddece94a8331eab4135b3734f043f42ce72cdf5b2a50f